These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33610444)

  • 41.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiological Wheeler staging system: a retrospective cohort analysis to improve the local staging of prostate cancer with multiparametric MRI.
    Russo F; Manfredi M; Panebianco V; Armando E; De Luca S; Mazzetti S; Giannini V; Mele F; Bollito E; Appendino E; Regge D; Porpiglia F
    Minerva Urol Nefrol; 2019 Jun; 71(3):264-272. PubMed ID: 30654601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer.
    Zumsteg ZS; Zelefsky MJ; Woo KM; Spratt DE; Kollmeier MA; McBride S; Pei X; Sandler HM; Zhang Z
    BJU Int; 2017 Nov; 120(5B):E87-E95. PubMed ID: 28464446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between American Urologic Association (AUA) urinary symptom score and disease stage in men with localized prostate cancer.
    Lehrer S; Stone NN; Droller MJ; Stock RG
    Urol Oncol; 2002; 7(2):73-6. PubMed ID: 12474526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study.
    Renard-Penna R; Rouprêt M; Comperat E; Ayed A; Coudert M; Mozer P; Xylinas E; Bitker MO; Grenier P
    Urol Oncol; 2013 May; 31(4):448-54. PubMed ID: 21775172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiparametric MRI - local staging of prostate cancer and beyond.
    Caglic I; Kovac V; Barrett T
    Radiol Oncol; 2019 May; 53(2):159-170. PubMed ID: 31103999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous whole-body
    Freitag MT; Kesch C; Cardinale J; Flechsig P; Floca R; Eiber M; Bonekamp D; Radtke JP; Kratochwil C; Kopka K; Hohenfellner M; Stenzinger A; Schlemmer HP; Haberkorn U; Giesel F
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):340-347. PubMed ID: 29038888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are staging investigations being overused in patients with low and intermediate risk prostate cancer?
    Kim L; Min M; Roos D; Nguyen L; Yeoh E
    J Med Imaging Radiat Oncol; 2015 Feb; 59(1):77-81. PubMed ID: 25186469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A clinician-centred programme for behaviour change in the optimal use of staging investigations for newly diagnosed prostate cancer.
    Rutledge AB; McLeod N; Mehan N; Regan TW; Ainsworth P; Chong P; Doyle T; White M; Sanson-Fisher RW; Martin JM
    BJU Int; 2018 May; 121 Suppl 3():22-27. PubMed ID: 29359883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of staging CT scans in the treatment of prostate cancer: a retrospective audit.
    Burcombe RJ; Ostler PJ; Ayoub AW; Hoskin PJ
    Clin Oncol (R Coll Radiol); 2000; 12(1):32-5. PubMed ID: 10749017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy.
    Salmasi A; Said J; Shindel AW; Khoshnoodi P; Felker ER; Sisk AE; Grogan T; McCullough D; Bennett J; Bailey H; Lawrence HJ; Elashoff DA; Marks LS; Raman SS; Febbo PG; Reiter RE
    J Urol; 2018 Sep; 200(3):564-572. PubMed ID: 29524506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer.
    Hara N; Okuizumi M; Koike H; Kawaguchi M; Bilim V
    Prostate; 2005 Feb; 62(2):140-7. PubMed ID: 15389803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer.
    Fulgham PF; Rukstalis DB; Turkbey IB; Rubenstein JN; Taneja S; Carroll PR; Pinto PA; Bjurlin MA; Eggener S
    J Urol; 2017 Oct; 198(4):832-838. PubMed ID: 28483574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer?
    Levran Z; Gonzalez JA; Diokno AC; Jafri SZ; Steinert BW
    Br J Urol; 1995 Jun; 75(6):778-81. PubMed ID: 7542138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of the 2013 American Urological Association early detection of prostate cancer guideline: who will we miss?
    Auffenberg GB; Meeks JJ
    World J Urol; 2014 Aug; 32(4):959-64. PubMed ID: 24946729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Limitations of abdominopelvic CT and multiparametric MR imaging for detection of lymph node metastases prior to radical prostatectomy.
    Peabody H; Lane BR; Qi J; Kim T; Montie JE; Moriarity A; Brede CM; Montgomery J;
    World J Urol; 2021 Mar; 39(3):779-785. PubMed ID: 32361876
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expressed prostatic secretion biomarkers improve stratification of NCCN active surveillance candidates: performance of secretion capacity and TMPRSS2:ERG models.
    Whelan C; Kawachi M; Smith DD; Linehan J; Babilonia G; Mejia R; Wilson T; Smith SS
    J Urol; 2014 Jan; 191(1):220-6. PubMed ID: 23669563
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J
    World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.